GANX · Gain Therapeutics, Inc.
$1.80
+0.03 (+1.69%)
At close · Aug 31
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our projected cash outflows for the upcoming periods raise substantial doubt about our ability to continue as a going concern for at least 12 months from the issuance of the financial statements included elsewhere in this Quarterly Report.”View the 10-Q filed Aug 11, 2026
Market Cap
$77.25M
Shares
43.64M
Stock transactions by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this stock yet.
Key facts
CIK
1819411
CUSIP
36269B105
13F (30d)
42 filings
42 filers
Visit website
Investor relations